Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Marshall Keith W. Director active across 1 company, notably Prometheus Biosciences, Inc.. In total, 7 reports have been published. Activity tracked since 9 December 2022. The latest transaction was disclosed on 2 June 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations7 total
87,973 sharesCommon StockSEC:0000899243-23-015754:0
78,162 shares@ US$3.1068.6% of flowCommon StockSEC:0001209191-23-034038:0
10,000 shares@ US$3.7010.3% of flowCommon StockSEC:0001209191-23-023869:0
10,000 shares@ US$3.7010.6% of flowCommon StockSEC:0001209191-23-017435:0
5,000 shares@ US$3.705.2% of flowCommon StockSEC:0001209191-23-010974:0
5,000 shares@ US$3.705.2% of flowCommon StockSEC:0001209191-23-004138:0
9,811 shares0Common StockSEC:0001209191-22-061089:0